Clinical Trials Logo

Stroke, Acute clinical trials

View clinical trials related to Stroke, Acute.

Filter by:

NCT ID: NCT04170647 Recruiting - Stroke, Acute Clinical Trials

Efficacy of Intravenous Tissue-type Plasminogen Activator on Acute Ischemic Stroke Patients With Large Vessel Occlusions

Start date: October 1, 2017
Phase:
Study type: Observational [Patient Registry]

This is an observational prospective study about the reperfusion rate of intravenous thrombolysis on ischemic stroke patients with large vessel occlusions and predictor factors of successful recanalization.

NCT ID: NCT04150835 Recruiting - Clinical trials for Acute Ischemic Stroke

Xingnaojing for Mild-to-severe Acute Ischemic Stroke

XMAS-2
Start date: March 19, 2020
Phase: Phase 4
Study type: Interventional

The main purpose of this trial is to determine whether Xingnaojing, intravenously administered within 24 hours of symptom onset, improves the daily living ability of acute ischemic stroke at 90 days.

NCT ID: NCT04129203 Recruiting - Stroke, Acute Clinical Trials

Versi Retriever Approving Trial in Japan

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

This is Versi Retriever mechanical thrombectomy device approving study in Japan. Multi center, single arm, prospective registry trial. Physicians control trial, conducted my N Sakai, Kobe City Medical Center General Hospital.

NCT ID: NCT04118998 Recruiting - Stroke, Acute Clinical Trials

Progressive Abduction Loading Therapy

PRALINE
Start date: August 27, 2021
Phase: N/A
Study type: Interventional

This study attempts to minimize the development of a common movement impairment following stroke known as "flexion synergy" that makes it extremely difficult to reach outward with the arm. Participants with acute/subacute stroke will receive one of two study interventions in addition to prescribed therapies in both inpatient rehabilitation and day-rehab. Participants will be followed for 1 year.

NCT ID: NCT04118790 Recruiting - Fatigue Clinical Trials

Microstructure Imaging in Stroke Patients

Start date: December 23, 2019
Phase:
Study type: Observational

The purpose of this study is to establish a methodological framework based on existing advanced neuroimaging technologies as a new clinical neuroimaging tool for assessment of possible affected brain connections in stroke and TIA patients. Thus, providing new insights into microstructural changes that may underline why those patients experience deficits like fatigue.

NCT ID: NCT04110652 Recruiting - Stroke, Acute Clinical Trials

Effect of Pulmonary Rehabilitation Program on Patients With Acute Ischemic Stroke, Mortality and Disability

Start date: February 3, 2019
Phase: N/A
Study type: Interventional

Severe stroke remains an important cause of mortality and morbidity, despite advances in disease management, acute treatment and secondary measures. Among all post-stroke complications, pneumonia constitutes a major complication with a strong impact on morbidity and mortality. Research also showed that a reduction in respiratory muscle and abdominal muscle strength contributed to pulmonary and respiratory dysfunction following a stroke. Low respiratory muscle function decreases the efficacy of rehabilitation because it leads to exercise intolerance in stroke patients. Thus, special exercise programs are needed to improve the pulmonary function and respiratory muscle strength of stroke patients The aim of pulmonary rehabilitation program is to enhance respiratory muscle resistance during breathing, thereby improving respiratory function. Previous studies demonstrated that pulmonary rehabilitation programs improved respiratory functions in cardiac disease and chronic obstructive pulmonary disease patients

NCT ID: NCT04092543 Recruiting - Stroke, Acute Clinical Trials

Validation of DRAGON Versus a Simplified DRAGON/Machine Learning

Start date: March 1, 2019
Phase:
Study type: Observational

The CT-DRAGON score can predict long-term functional outcome after acute stroke treated by thrombolysis. However, implementation in clinical practice is hampered by a lack of validation in the broad spectrum of stroke patients undergoing thrombectomy, whether or not in combination with thrombolysis or conservative treatment. Furthermore, the CT-DRAGON score considers multiple items, which are not always readily available in every setting. This study aims to investigate whether either a simplified version of the CT-DRAGON score with only three clinical items or a machine learning technique could be as powerful and more feasible.

NCT ID: NCT04057690 Recruiting - Stroke, Acute Clinical Trials

Automatic PredICtion of Edema After Stroke

APICES
Start date: April 1, 2019
Phase:
Study type: Observational

To use machine learning for early detection of malignant brain edema in patients with MCA ischemia

NCT ID: NCT03934021 Recruiting - Stroke Clinical Trials

Gut Microbiota in Acute Stroke Patients

Start date: July 1, 2018
Phase:
Study type: Observational

This study is to find out the significance of gut-microbiota in acute stroke patients, including their neurological, radiological outcomes as well as their stroke mechanisms.

NCT ID: NCT03897478 Recruiting - Stroke Clinical Trials

Biomarkers of Acute Stroke in Clinic

BASIC
Start date: April 1, 2019
Phase:
Study type: Observational

The proposed study will investigate the clinical use of the ISCDX test that may differentiate between diverse stroke etiologies as listed below: Aim 1: Differentiate between cardioembolic and large artery atherosclerotic ischemic strokes, when hemorrhagic stroke is ruled out, as defined by TOAST classification of subtypes of acute ischemic stroke. Aim 2: In cases of ischemic strokes of unknown or "cryptogenic" etiology, determine the ability of biomarker blood tests to predict etiology between cardioembolic and large artery atherosclerotic.